Real-world effectiveness and safety of sofosbuvir plus daclatasvir with or without ribavirin for genotype 2 chronic hepatitis C in Taiwan

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint Dive into the research topics of 'Real-world effectiveness and safety of sofosbuvir plus daclatasvir with or without ribavirin for genotype 2 chronic hepatitis C in Taiwan'. Together they form a unique fingerprint.

Medicine & Life Sciences